Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation.
Allergy. 2023 Jun;78(6):1639-1653. doi: 10.1111/all.15663. Epub 2023 Feb 14.
Allergy. 2023.
PMID: 36721963
Clinical Trial.
Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell®.
Rabdano SO, Ruzanova EA, Pletyukhina IV, Saveliev NS, Kryshen KL, Katelnikova AE, Beltyukov PP, Fakhretdinova LN, Safi AS, Rudakov GO, Arakelov SA, Andreev IV, Kofiadi IA, Khaitov MR, Valenta R, Kryuchko DS, Berzin IA, Belozerova NS, Evtushenko AE, Truhin VP, Skvortsova VI.
Rabdano SO, et al. Among authors: ruzanova ea.
Vaccines (Basel). 2023 Apr 20;11(4):874. doi: 10.3390/vaccines11040874.
Vaccines (Basel). 2023.
PMID: 37112786
Free PMC article.
Item in Clipboard
Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine.
Rabdano S, Ruzanova E, Makarov D, Vertyachikh A, Teplykh V, Rudakov G, Pletyukhina I, Saveliev N, Zakharov K, Alpenidze D, Vasilyuk V, Arakelov S, Skvortsova V.
Rabdano S, et al. Among authors: ruzanova e.
Vaccines (Basel). 2024 Jan 19;12(1):100. doi: 10.3390/vaccines12010100.
Vaccines (Basel). 2024.
PMID: 38276672
Free PMC article.
Item in Clipboard
Cite
Cite